NEW YORK (GenomeWeb) – PerkinElmer reported after the close of the market on Thursday that is third quarter revenues were up 3 percent, or 10 percent on a constant-currency basis, compared to the same period a year ago.

For the three months ended Oct. 4, PerkinElmer posted Q3 revenues of $563.4 million, up from $542.0 million for Q3 a year ago and beating analysts' consensus estimate of $554.9 million. The company reported organic revenue growth of 6 percent year over year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.